Search
for
Sort by
Research 301–330 of 339
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- The Role of Probiotics and Synbiotics on Hirsutism
- Targeted Determination of Residual Sex Hormones in Cosmetics Using Magnetic Solid-Phase Extraction with Isotope-Labeled Internal Standards by UHPLC-MS/MS
- Pathophysiological mechanisms implicated in postpartum depression
- Uterine transplantation in transgender women
- Sex hormones and acne
- Stroke Risk Factors Unique to Women
- Treatment of hirsutism and acne in hyperandrogenism
- Sex differences in arterial hypertension
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Complications of Subcutaneous Contraception: A Review
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Skin, hair and beyond: the impact of menopause
- National consensus on the management of patients with hyperandrogenism (2016)
- Gender effects in allergology – Secondary publications and update
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
- IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Affirmation as Male
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- No. 350-Hirsutism: Evaluation and Treatment
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
- Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
- Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation
- Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist